Recent research shows lipid nanoparticles delivering mRNA can reduce tau protein aggregates in Alzheimer’s models, with Moderna advancing clinical trials and regulatory support accelerating deve...
Recent advances in mRNA technology for cancer vaccines show promise with improved stability, targeted delivery, and AI-driven antigen design, transforming immunotherapy approaches. Cutting-edge mRNA v...
Breakthrough cubosome technology enhances bioavailability of curcumin and berberine, offering precise pancreatic beta-cell targeting and improved glycemic control in preclinical trials, challenging tr...
